Synthesis and in vitro evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PET neuroimaging probes
- 1 August 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 136, 548-560
Abstract
No abstract availableKeywords
Funding Information
- China Scholarship Council
- Deutscher Akademischer Austauschdienst (57129895)
This publication has 34 references indexed in Scilit:
- Phosphodiesterase‐5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionMediators of Inflammation, 2015
- The Epidemiological Scale of Alzheimer’s DiseaseJournal of Clinical Medicine Research, 2015
- Advances in targeting cyclic nucleotide phosphodiesterasesNature Reviews Drug Discovery, 2014
- Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington’s DiseasePLOS ONE, 2013
- Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2013
- Phosphodiesterases as Therapeutic Targets for Alzheimer's DiseaseACS Chemical Neuroscience, 2012
- Therapeutic approaches to Alzheimer's diseaseBrain, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brainJournal of Comparative Neurology, 2003
- Immunohistochemical Localization of cGMP-binding cGMP-specific Phosphodiesterase (PDE5) in Rat TissuesJournal of Histochemistry & Cytochemistry, 2000